Annandale, VA; August 24, 2020
The Clinical Alliance for Research and Education (CARE-ID) Begins Recruiting Adults for COVID-19 Investigation Vaccine Clinical Trial
CARE-ID announced today it has begun recruiting volunteers in a clinical research study to evaluate the safety and effectiveness of a vaccine candidate against COVID-19. Sponsored by Pfizer, the C4591001 (NCT04368728) is a phase 1/2/3, placebo-controlled, randomized, observer-blind, dose-finding study to evaluate the safety, tolerability, immunogenicity, and efficacy of SARS-COV-2-RNA vaccine candidates against COVID-19 in health adults.